DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNews Health & Fitness Technology Tech News

DeviceTalks Podcast Network episodes

April 15, 2025 New episode of Structural Heart Talks is about to go live...
TODAY we will hear from Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, on how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case.

Get Ready.
1 min
April 15, 2025 Edwards’ Joe Nuzzolese on planning for disruption, prioritizing patients & automating supply chains
In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case.
Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability. He details how the company strategically leverages dual sourcing, inventory buffering, and global distribution flexibility to maintain operations, even when borders close or suppliers face challenges.
He also unpacks the need for automation and digital integration, explains how Edwards connects employees to patient outcomes to instill purpose, and reveals why fostering innovation readiness is central to their long-term strategy.
Thank you to Daikin America for sponsoring this episode of Structural Heart Talks. To learn more about Daikin America’s products for your medical application visit https://daikin-america.com.
Wait, there’s more! Want to learn more about Daikin America’s new Co-Extrusion technology? Click here for a high resolution image with more detail.
Thank you for listening to the Structural Heart Talks podcast.
Subscribe to Structural Heart Talks or the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks on YouTube Podcasts to ensure you never miss an episode.
36 min
April 11, 2025 CorVista using AI to get patients the correct cardiac care; Why ASCs should matter to MedTechs
In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO.
CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care.
Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech.
Finally, MassDevice Editor Chris Newmarker and Tom talk about the impact President Trump’s tariff tactics are having on the MedTech industry.
This episode is brought to you by DeviceTalks Boston, April 30 - May 1. Boston.DeviceTalks.com
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
1 hr 24 min
April 04, 2025 Hachach-Haram: How Proximie builds digital bridges to the OR; Norris: Q1 VC, the good, the bad
In this episode of the DeviceTalks Weekly Podcast, Dr. Nadine Hashash-Haram discusses her journey as a surgeon and the founder of Proxime, a digital health platform that enhances surgical procedures through technology. She shares insights on the evolution of Proxime, its impact on healthcare systems, and the importance of collaboration with medical device companies.
Before that interview, Jonathan Norris, managing director at HSBC Innovation Banking, reviews first quarter MedTech VC investment numbers. There’s good news, bad news and a lot of in-between as privately held medical device companies.
This episode is sponsored by DeviceTalks Minnesota. Find the discount code inside this podcast. Go to Minnesota.DeviceTalks.com to register for the June 11 event.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
1 hr 8 min
March 28, 2025 Fogarty’s Cleeland on impact of MedTech innovation; Soriano highlights Baxter’s hurricane response
In this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute. Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large.
The Fogarty Institute is also promoting the Thomas J. Fogarty prize for medical innovation, a $100,000 prize for one person or a small group of people who have broken new ground in the industry. Go to this article at Medical Design & Outsourcing for more information.
https://www.medicaldesignandoutsourcing.com/mike-mussallem-tom-fogarty-prize-medtech-innovation/
Before that conversation, Host Tom Salemi and Holly Scott, managing partner at The Mullings Group, interviewed Cecilia Soriano, global president of Infusion Therapies and Technologies, at Baxter. We’ll preview Soriano’s interview at DeviceTalks Boston where she’ll talk about Baxter’s recovery from Hurricane Helene.
But we’ll start the episode off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers including the FDA, HHS, Alcon, Abbott and Johnson & Johnson MedTech.
Thanks for listening to this episode of the DeviceTalks Weekly podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
1 hr 26 min
March 21, 2025 Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.
Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics.
Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
1 hr 5 min
March 14, 2025 BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.
Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely.
But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
1 hr 18 min
March 07, 2025 Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?
In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers.
But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies.
You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
54 min
March 04, 2025 Enovis’ Vogt on driving recon growth past $1B w/ M&A, knee breakthroughs and foot & ankle expansion
In the kickoff episode of Season 2 of Ortho Innovation Talks, Louie Vogt, Group President of Reconstructive at Enovis, takes us inside the company’s strategic growth in orthopedics. Vogt shares how Enovis has transformed into a major player in the reconstructive space through key acquisitions and bold bets on innovative implant designs.
He discusses the evolution of knee implants, highlighting Enovis’ pioneering work with kinematically driven bearings and the dual pivot knee concept. Vogt also touches on the growing role of robotics and enabling technologies in orthopedic surgery, emphasizing how these advancements are changing the surgeon experience and patient outcomes.
Beyond knees, Vogt explores Enovis’ expansion into foot and ankle reconstruction—a rapidly growing market—and how the company is leveraging M&A and innovation to carve out a competitive edge. As Enovis looks ahead to 2025, Vogt teases major product launches in shoulders, hips, and extremities, signaling another big year for the company.
This conversation comes to you courtesy of our sponsor, Paragon Medical. To learn more about how Paragon Medical can help you bring your device to market faster, visit them at www.paragonmedical.com.
Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.
WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!
33 min
February 28, 2025 Hear Part 1 of Lungpacer Medical’s AeroPace Story; Be part of the conclusion at DeviceTalks Boston
In this episode of the DeviceTalks Weekly Podcast, it’s a DeviceTalks Team Up. Editorial Director Tom Salemi and Managing Editor Kayleen Brown interview Doug Evans, CEO and President of Lungpacer Medical. Evans shares the tragic reason he vowed to start a company that would help wean patients off ventilators. We’ll hear his success story in the podcast, but join us at DeviceTalks Boston to hear the story behind the AeroPace technologies as Evans will be joined by Lungpacer COO Viral Thakkar and Mike Longo, vice president of product development.
Register to attend DeviceTalks Boston at Boston.DeviceTalks.com. If you missed our early bird rate use the code mentioned in the podcast on March 1 and 2.
Before the DeepDive conversation, we’ll have Mass Device Honcho Chris Newmarker’s Newsmakers - Medtronic, Solventum, FDA layoffs, Boston Scientific, and Teleflex.
Jim Hammerand, managing editor of Medical Design & Outsourcing, opens with an overview of the magazine’s current Min-Vasive issue. You can find all the articles mentioned at medicaldesignandoutsourcing.com.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
1 hr 24 min

About DeviceTalks Podcast Network

From the publisher's feed

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry.